Clinical Gastroenterology Vol.29 No.07 ( Jun, 2014)

Thesis List

• 1-1 Discovery of HCV and Its Significance
  Tatsuo Miyamura

• 1-2 Mechanisms of HCV Replication
  Toru Okamoto

• 1-3 The Mechanisms of Persistent HCV Infection
  Hiromichi Dansako

• 1-4 Recent Advancement of HCV Culture Systems
  Takaji Wakita

• 1-5 Cellular Metabolome during Hepatitis C Virus Infection
  Hideki Aizaki

• 1-6 Relationship between HCV Genotype and HCV-induced Liver Diseases
  Masaaki Korenaga

• 1-7 Hepatitis C Virus and MicroRNA
  Motoyuki Otsuka

• 1-8 HCV-infected Human Hepatocyte Chimeric Mice
  Michio Imamura

• 2-1 Epidemiology of Hepatitis C Virus Infection (1)
  Junko Tanaka

• 2-2 Epidemiology of Hepatitis C Virus Infection (2)
  Keiko Katayama

• 2-3 The Present of Transfusion-transmitted Hepatitis
  Shigeharu Uchida

• 2-4 Hepatitis C Virus and Residential Medical Examination
  Akihito Sakai

• 2-5 Role of Hepatologists in the Manegement of HCV-related Disease
  Masakuni Tateyama

• 2-6 Chronic Hepatitis in Childhood
  Ayano Inui

• 3-1 Natural History of Chronic Hepatitis C
  Satoru Joshita

• 3-2 Acute Hepatitis C and Recent Trend
  Tatsuo Miyamura

• 3-3 Pathological Characteristics of Chronic Hepatitis C
  Masayoshi Kage

• 3-4 Gene Expression Profiling of HCV Infected Liver
  Masao Honda

• 3-5 Iron Metabolic Disorder in Chronic Hepatitis C
  Sohji Nishina

• 3-6-1 JSH Guidelines for the Management of Hepatitis C Virus Infection
  Atsushi Tanaka

• 3-6-2 Viral Factors Influencing the Treatment Responce in Hepatitis C Virus Infection
  Shinya Maekawa

• 3-6-3 Host Factors : IL28B and ITPA
  Kentaro Matsuura

• 3-6-4 Innate Immunity and Anti-viral Response in Patients with Chronic Hepatitis C
  Yasuhiro Asahina

• 3-6-5 Data Mining Analysis for Chronic Hepatitis C
  Masayuki Kurosaki

• 3-6-6 Simeprevir for the Treatment for Chronic Hepatitis C
  Tetsuo Takehara

• 3-6-7 Low-dose and Maintenance IFN Therapy
  Hiroshi Yatsuhashi

• 3-6-8 The Most Up-to-date, Interferon Free Therapy Using Direct-acting Antivirals
  Hiromitsu Kumada

• 3-6-9 Trend in Anti-HCV Drug Development in the World
  Kazuaki Inoue

• 3-7 Liver Supporting Therapy for Chronic Hepatis C
  Norie Yamada

• 3-8 Impact of Metabolic Factors on Therapy for Hepatitis C
  Kohichiroh Yasui

• 3-9 Antiviral Treatment for HCV after Liver Transplantation
  Nobuhisa Akamatsu

• 4-1-1 Trend in Incidence and Mortality of Liver Cancer in Japan
  Hideo Tanaka

• 4-1-2 Is There Any Change in High Risk Populations ?
  Ryosuke Tateishi

• 4-1-3 The Mechanism of Hepatocarcinogenesis by Viral Factors
  Takeya Tsutsumi

• 4-1-4 An Investigation of Genetic Predisposition to Hepatocellular Carcinoma
  Naoya Kato

• 4-1-5 Whole Genome Sequencing of HCV-positive Hepatocellular Carcinoma
  Tatsuhiro Shibata

• 4-2 Prevention of Hepatocellular Carcinoma by Anti-viral Therapy
  Shuhei Nishiguchi

• 4-3 Prediction of Hepatocarcinogenesis with Amino Acid Substitutions of HCV Core Region
  Norio Akuta

• 4-4 HCV Related Hepatocellular Carcinoma and Obesity
  Takamasa Ohki

• 4-5 Aging & Hepatocarcinogenesis in Patients with HCV Infection
  Takumi Kawaguchi

• 4-6 Treatment for HCV Related Hepatocellular Carcinoma -- Changes in Prognosis
  Hiroki Nishikawa

• 5-1 Hepatitis C and Mucosal Lesions
  Yumiko Nagao

• 5-2 Hepatitis C and Autoimmune Disease
  Chiaki Okuse

• 5-3 Hepatitis C Associated Malignant Lymphoma
  Takayoshi Ito